OL-FS13 alleviates experimental cerebral ischemia-reperfusion injury. 2022

Naixin Liu, and Yilin Li, and Ying Yang, and Longjun Shu, and Yixiang Liu, and Yutong Wu, and Dandan Sun, and Zijian Kang, and Yue Zhang, and Dan Ni, and Ziqi Wei, and Shanshan Li, and Meifeng Yang, and Ying Wang, and Jun Sun, and Xinwang Yang
Department of Anatomy and Histology & Embryology, Faculty of Basic Medical Science, Kunming Medical University, Kunming 650500, Yunnan, China.

Cerebral ischemia-reperfusion (I/R) is the main cause of neurological injury after stroke. However, existing treatments for I/R injury are relatively poor, and relevant drugs need to be further explored. Amphibians have received increasing attention as a resource bank of bioactive peptides. However, reports on neuroprotective peptides from amphibians remain extremely rare. Here, we identified a new neuroprotective peptide (OL-FS13, amino acid sequence: FSLLLTWWRRRVC) from the odorous frog species Odorrana livida using a constructed cDNA library. OL-FS13 significantly improving infarct volume, behavioral and histological abnormalities in rats, and also showed neuroprotective activities in PC12 cell (by oxygen glucose deprivation/reoxygenation, OGD/R). Mechanistically, OL-FS13 increased the level of antioxidative enzymes to resist oxidative stress and alleviated endoplasmic reticulum (ER) stress induced by I/R and OGD/R. The use of ML385 (Nrf2 inhibitor) indicated that OL-FS13 relieved nerve damage caused by oxidative and ER stress by increasing the nuclear displacement of Nrf2. Collectively, this research provides a novel drug candidate for the clinical cerebral I/R curation.

UI MeSH Term Description Entries
D009479 Neuropeptides Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells. Neuropeptide
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D002544 Cerebral Infarction The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction). Anterior Choroidal Artery Infarction,Cerebral Infarct,Infarction, Cerebral,Posterior Choroidal Artery Infarction,Subcortical Infarction,Cerebral Infarction, Left Hemisphere,Cerebral Infarction, Right Hemisphere,Cerebral, Left Hemisphere, Infarction,Cerebral, Right Hemisphere, Infarction,Infarction, Cerebral, Left Hemisphere,Infarction, Cerebral, Right Hemisphere,Infarction, Left Hemisphere, Cerebral,Infarction, Right Hemisphere, Cerebral,Left Hemisphere, Cerebral Infarction,Left Hemisphere, Infarction, Cerebral,Right Hemisphere, Cerebral Infarction,Right Hemisphere, Infarction, Cerebral,Cerebral Infarctions,Cerebral Infarcts,Infarct, Cerebral,Infarction, Subcortical,Infarctions, Cerebral,Infarctions, Subcortical,Infarcts, Cerebral,Subcortical Infarctions
D002545 Brain Ischemia Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. Cerebral Ischemia,Ischemic Encephalopathy,Encephalopathy, Ischemic,Ischemia, Cerebral,Brain Ischemias,Cerebral Ischemias,Ischemia, Brain,Ischemias, Cerebral,Ischemic Encephalopathies
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015427 Reperfusion Injury Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA. Ischemia-Reperfusion Injury,Injury, Ischemia-Reperfusion,Injury, Reperfusion,Reperfusion Damage,Damage, Reperfusion,Injury, Ischemia Reperfusion,Ischemia Reperfusion Injury,Ischemia-Reperfusion Injuries,Reperfusion Damages,Reperfusion Injuries
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D051267 NF-E2-Related Factor 2 A basic-leucine zipper transcription factor that was originally described as a transcriptional regulator controlling expression of the BETA-GLOBIN gene. It may regulate the expression of a wide variety of genes that play a role in protecting cells from oxidative damage. Nfe2l2 Protein,Nuclear Factor (Erythroid-Derived 2)-Like 2 Protein,Nuclear Factor E2-Related Factor 2,NF E2 Related Factor 2,Nuclear Factor E2 Related Factor 2
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Naixin Liu, and Yilin Li, and Ying Yang, and Longjun Shu, and Yixiang Liu, and Yutong Wu, and Dandan Sun, and Zijian Kang, and Yue Zhang, and Dan Ni, and Ziqi Wei, and Shanshan Li, and Meifeng Yang, and Ying Wang, and Jun Sun, and Xinwang Yang
November 2023, Biological & pharmaceutical bulletin,
Naixin Liu, and Yilin Li, and Ying Yang, and Longjun Shu, and Yixiang Liu, and Yutong Wu, and Dandan Sun, and Zijian Kang, and Yue Zhang, and Dan Ni, and Ziqi Wei, and Shanshan Li, and Meifeng Yang, and Ying Wang, and Jun Sun, and Xinwang Yang
March 2021, Anatomical record (Hoboken, N.J. : 2007),
Naixin Liu, and Yilin Li, and Ying Yang, and Longjun Shu, and Yixiang Liu, and Yutong Wu, and Dandan Sun, and Zijian Kang, and Yue Zhang, and Dan Ni, and Ziqi Wei, and Shanshan Li, and Meifeng Yang, and Ying Wang, and Jun Sun, and Xinwang Yang
March 2019, Frontiers in bioscience (Landmark edition),
Naixin Liu, and Yilin Li, and Ying Yang, and Longjun Shu, and Yixiang Liu, and Yutong Wu, and Dandan Sun, and Zijian Kang, and Yue Zhang, and Dan Ni, and Ziqi Wei, and Shanshan Li, and Meifeng Yang, and Ying Wang, and Jun Sun, and Xinwang Yang
October 2019, Molecular genetics & genomic medicine,
Naixin Liu, and Yilin Li, and Ying Yang, and Longjun Shu, and Yixiang Liu, and Yutong Wu, and Dandan Sun, and Zijian Kang, and Yue Zhang, and Dan Ni, and Ziqi Wei, and Shanshan Li, and Meifeng Yang, and Ying Wang, and Jun Sun, and Xinwang Yang
August 2019, Scientific reports,
Naixin Liu, and Yilin Li, and Ying Yang, and Longjun Shu, and Yixiang Liu, and Yutong Wu, and Dandan Sun, and Zijian Kang, and Yue Zhang, and Dan Ni, and Ziqi Wei, and Shanshan Li, and Meifeng Yang, and Ying Wang, and Jun Sun, and Xinwang Yang
August 2022, Neural regeneration research,
Naixin Liu, and Yilin Li, and Ying Yang, and Longjun Shu, and Yixiang Liu, and Yutong Wu, and Dandan Sun, and Zijian Kang, and Yue Zhang, and Dan Ni, and Ziqi Wei, and Shanshan Li, and Meifeng Yang, and Ying Wang, and Jun Sun, and Xinwang Yang
May 2022, Neurochemical research,
Naixin Liu, and Yilin Li, and Ying Yang, and Longjun Shu, and Yixiang Liu, and Yutong Wu, and Dandan Sun, and Zijian Kang, and Yue Zhang, and Dan Ni, and Ziqi Wei, and Shanshan Li, and Meifeng Yang, and Ying Wang, and Jun Sun, and Xinwang Yang
April 2021, Naunyn-Schmiedeberg's archives of pharmacology,
Naixin Liu, and Yilin Li, and Ying Yang, and Longjun Shu, and Yixiang Liu, and Yutong Wu, and Dandan Sun, and Zijian Kang, and Yue Zhang, and Dan Ni, and Ziqi Wei, and Shanshan Li, and Meifeng Yang, and Ying Wang, and Jun Sun, and Xinwang Yang
June 2022, CNS neuroscience & therapeutics,
Naixin Liu, and Yilin Li, and Ying Yang, and Longjun Shu, and Yixiang Liu, and Yutong Wu, and Dandan Sun, and Zijian Kang, and Yue Zhang, and Dan Ni, and Ziqi Wei, and Shanshan Li, and Meifeng Yang, and Ying Wang, and Jun Sun, and Xinwang Yang
November 2022, ACS biomaterials science & engineering,
Copied contents to your clipboard!